	Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study. Ann Surg Oncol Kuemmel S, Fasching PA, Schmid P, Harbeck N, Takahashi M, Untch M, Boileau JF, Cortes J, Dent R, O'Shaughnessy J, Pusztai L, Foukakis T, Park YH, Hui R, Cardoso F, Denkert C, Jia L, Pan W, Karantza V, McArthur H. PMID: 41739398 [PubMed - as supplied by publisher]
	Correction: Exploring the lived experiences of women with metastatic breast cancer and their HRQoL questionnaire preferences: a qualitative study. Qual Life Res Tolstrup L, Vogsen M, Hildebrandt MG, Sørensen RW, Maguire R, Dieperink KB. PMID: 41739269 [PubMed - in process]
	The impact of absent vulvar cancer screening guidelines on outcomes of vulvar squamous cell carcinoma: a national cancer database study. Cancer Causes Control Folino G, Byrne E, Eiden MK, Vasa M, Silberstein P, DiBlasi M. PMID: 41739264 [PubMed - indexed for MEDLINE]
	The impact of HER2 low positivity in hormone receptor-positive, HER2-negative breast cancer treated with neoadjuvant chemotherapy. Cancer Biomark Ersoy M. PMID: 41739091 [PubMed - indexed for MEDLINE]
	Bisphosphonates in breast cancer radiotherapy: associations with skeletal complications and treatment outcomes - a retrospective cohort study. Front Oncol Baalbaki K, Hemdanieh M, Yammine J, Sleem B, Sawaf S, Lakkis R, Nassereddine M, Bodgi L. PMID: 41737485 [PubMed]
	Global, regional, and national burden of ovarian cancer due to high BMI, 1990-2021 and projections to 2050: a systematic analysis based on the global burden of disease 2021 study. Front Nutr Xu S, Fu X, Wang M. PMID: 41737342 [PubMed]
	Association of immuno-inflammatory biomarkers with response to neoadjuvant chemotherapy and prognosis in HER2-positive breast cancer: dual-center clinical evidence. Front Immunol Wu X, Wu S, Tang M, Xie L, Liu J, Liao J, Wang J, Yang H. PMID: 41737214 [PubMed - indexed for MEDLINE]
	Unveiling trends and clinical progress of immunotherapy for endometrial cancer: a scientometric and clinical trial landscape analysis. Front Immunol Liu R, Shan W, Hu Z, Wang H, Wang Z, Yang L, Guo R. PMID: 41737210 [PubMed - indexed for MEDLINE]
	Efficacy of Mindfulness-based complementary alternative therapy on physical and mental stress, self-efficacy, and coping styles of patients undergoing breast cancer surgery. Pak J Med Sci Wang Y, Ding Z. PMID: 41737190 [PubMed]
	Value of Radiomics Based on DCE-MRI in distinguishing benign and malignant breast lesions: Predicting Histological Grade and Lymph Node Metastasis of Breast Cancer. Pak J Med Sci Li P, Xu H. PMID: 41737186 [PubMed]
	A Co-Design Study Developing an Early Prototype Intervention to Support Oral Anticancer Medication Use in Breast Cancer. Patient Prefer Adherence Seo Y, Hudmon KS, Weddle KJ, Yih Y, Miller KD, Abebe E. PMID: 41737150 [PubMed]
	Beyond glycemic control: molecular mechanisms of metformin in modulating cytokine networks in polycystic ovary syndrome. Front Endocrinol (Lausanne) Ullah A, Chen Y, Zhang F, Shen B. PMID: 41737049 [PubMed - indexed for MEDLINE]
	Association Between Peripheral Blood Lymphocyte Count and HER2 Status in Breast Cancer: A Retrospective Study. Int J Womens Health Liang H, Lin Y, Pan K, Wang J, Xie X, Ding M, Lin J. PMID: 41736761 [PubMed]
	Mechanisms of Gualou Beimu Yin in suppressing the development and metastasis of triple-negative breast cancer: an integrated study based on network pharmacology, transcriptomics, and metabolomics. J Tradit Chin Med Ao J, Shuang L, Tingting G, Haoran Z, Wenyuan G, Xiongzhi WU. PMID: 41736431 [PubMed - indexed for MEDLINE]
	Dormancy and Recurrence in Breast Cancer Bone Metastasis: From Mechanisms to Clinical Translation. Adv Biol (Weinh) Sun Z, Li B, Chen Z, Zhang Z. PMID: 41736249 [PubMed - indexed for MEDLINE]
	ASO Author Reflections: Large Language Models in Breast Cancer Decision-Making: Lessons from the St. Gallen International Breast Cancer Consensus. Ann Surg Oncol Pan Y, Zhu L. PMID: 41735729 [PubMed - as supplied by publisher]
	ASO Visual Abstract: St. Gallen International Breast Cancer Consensus-Based Clinical Decision Validation: Concordance Assessment Between Deep Large Language Model Outputs and Global Expert Panel Recommendations. Ann Surg Oncol Pan Y, Duan C, Du J, Zhang J, Du K, Zhang C, Liu Z, Zhang W, Wang B, Ren Y, Sun Z, Zhu L. PMID: 41735724 [PubMed - as supplied by publisher]
	Neurodiversity-Affirming Principles in Oncology Treatment: A Lived-Experience Case Study. Psychooncology Trevethick R, Baron-Cohen S, Weir E, Allison C, Fysh MC, Laplante DP, Dey M, Opie JE. PMID: 41735202 [PubMed - indexed for MEDLINE]
	End-to-end integrative segmentation and radiomics prognostic models for risk stratification of high-grade serous ovarian cancer: a retrospective multicohort study. Lancet Digit Health Linton-Reid K, Lu H, Wengert G, Fotopoulou C, Lee P, Petta F, Russo L, Avensani G, Arshad M, Harter P, Chen M, Boubnovski MM, Hindocha S, Hunter B, Posma JM, Rockall A, Aboagye EO. PMID: 41735102 [PubMed - as supplied by publisher]
	[A new approach to health care evaluation: Assessing the PopGrouper for matching and morbidity measurement using the disease management programs for CHD and breast cancer]. Z Evid Fortbild Qual Gesundhwes Hengel P, Tsatsaronis C, Busse R, Quentin W. PMID: 41735094 [PubMed - as supplied by publisher]

Articles 1 - 20 / 324902

Page 1 of 16246



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy